In our study, we first analyzed the expression of Robo1, Robo2, Robo3, Slit1, Slit2, and Slit3 in the SF of patients with RA and continued to evaluate the influence of Robo3 expression and effects of Slit3 on RASF as a potential therapeutic tool. Here, ROBO3 is linked to rheumatoid arthritis.